Nonetheless, NfL could be a valuable tool to supplement and fasten existing diagnostic processes to reduce the time from first clinical event to diagnosis, and predict future conversion from RIS and CIS to clinically definitive MS (CDMS) discussed below. Here, NEFL is linked to in situ carcinoma.